Advertisement
Screener

YARROW BIOSCIENCE, INC. (YARW) EBITDA

YARROW BIOSCIENCE, INC. (YARW) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$3.10M*; Operating income -$3.10M; Depreciation and amortization $6.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$3.81M; Operating income (m); Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA -$7.54M*; Operating income -$7.54M; Depreciation and amortization $6.00K*.
  • 2025-03-31: Basis Reported; EBITDA -$9.19M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$3.10M*-$3.10M$6.00K*$97.00K-3191.75%*(m)-$1.99M*(m)$788.00K(m)$0.00
2026-03-31Reported-$3.81M(m)(m)(m)-4430.23%(m)-$4.08M(m)$817.00K(m)$0.00
2025-06-30Reported-$7.54M*-$7.54M$6.00K*$69.00K-10921.74%*(m)-$10.80M*(m)$4.88M(m)$0.00
2025-03-31Reported-$9.19M(m)(m)(m)-4550.00%(m)-$11.46M(m)$6.12M(m)$0.00
2024-09-30Reported(m)-$13.09M(m)$121.00K(m)(m)-$8.51M*(m)$10.25M(m)$0.00
2024-06-30Reported-$10.40M*-$10.40M$0.00*$198.00K-5250.51%*(m)-$8.48M*(m)$7.31M(m)$0.00
2024-03-31Reported-$7.38M(m)(m)(m)-7530.61%(m)-$7.98M(m)$3.71M(m)$0.00
2023-12-31Reported-$6.83M(m)(m)(m)-8989.47%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$6.23M*-$6.23M$0.00*$114.00K-5468.42%*(m)-$5.15M*(m)$3.32M$3.03M$0.00
2023-06-30Reported-$10.32M*-$10.32M$0.00*$135.00K-7642.96%*(m)-$9.57M*(m)$7.23M$3.22M$0.00
2023-03-31Reported-$5.88M(m)(m)(m)-5934.34%(m)-$5.48M(m)$2.73M$3.24M$0.00
2022-12-31Reported-$8.14M(m)(m)(m)-135650.00%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$9.16M*-$9.33M$171.00K*$167.00K-5486.23%*(m)-$7.13M*(m)$5.55M$3.95M$0.00
2022-06-30Reported-$8.28M*-$8.29M$12.00K*$126.00K-6567.46%*(m)-$8.22M*(m)$4.11M$4.30M$0.00
2022-03-31Reported-$8.65M(m)(m)(m)-4857.87%(m)-$9.04M(m)$4.45M$4.42M$0.00
2021-12-31Reported-$8.82M(m)(m)(m)-3230.77%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$10.74M*-$10.77M$28.00K*$133.00K-8074.44%*$0.00*-$17.54M*$1.05M$5.92M$4.98M$0.00
2021-06-30Reported-$9.51M*-$9.54M$28.00K*$295.00K-3225.08%*$0.00*-$16.26M*$795.00K$5.05M$4.79M$0.00
2021-03-31Reported-$9.73M(m)(m)(m)-4230.43%$0.00-$12.55M$601.00K$4.25M$5.73M$0.00
2020-12-31Reported-$21.9M(m)(m)(m)-511.01%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$23.42M*-$23.49M$67.00K*$3.27M-716.55%*$0.00*-$23.64M*$371.00K$6.62M$19.77M$1.00K
2020-06-30Reported-$167.08M*-$167.18M$94.00K*$11.69M-1429.53%*$71.00K*-$35.86M*$216.00K$13.12M$26.46M-$259.00K
2020-03-31Reported-$39.8M(m)(m)(m)-2274.06%$42.00K-$52.21M$271.00K$15.95M$25.41M$0.00
2019-12-31Reported-$37.34M(m)(m)(m)-27657.04%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$23.11M*-$23.20M$93.00K*$0.00(m)$407.00K*-$21.79M*$0.00$12.45M$10.75M$0.00
2019-06-30Reported-$19.27M*-$19.36M$87.00K*$0.00(m)$316.00K*-$12.72M*$0.00$12.56M$6.80M$0.00
2019-03-31Reported-$15.81M(m)(m)(m)-5132.47%$138.00K-$16.64M(m)$10.85M$5.34M-$176.00K
2018-09-30Reported(m)-$13.70M(m)(m)(m)(m)-$12.17M*(m)$10.67M(m)(m)
2018-06-30Reported(m)-$9.17M(m)(m)(m)(m)-$12.74M*(m)$16.23M(m)(m)
2018-03-31Reported(m)-$13.22M(m)(m)(m)(m)-$11.20M(m)$11.02M(m)(m)
2017-09-30Reported(m)-$8.34M(m)(m)(m)(m)-$12.52M*(m)$8.01M(m)(m)
2017-06-30Reported(m)-$6.22M(m)(m)(m)(m)$37.00K*(m)$5.46M(m)(m)
2017-03-31Reported(m)-$5.55M(m)(m)(m)(m)-$5.58M(m)$4.99M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$29.73M(m)(m)(m)-5215.09%(m)-$33.12M(m)$19.24M(m)$4.00K
2024-12-31Reported-$43.63M(m)(m)(m)-8709.18%(m)-$33.97M(m)$30.95M(m)$4.00K
2023-12-31Reported-$29.26M(m)(m)(m)-6900.47%(m)-$25.34M(m)$16.31M(m)$0.00
2022-12-31Reported-$34.22M(m)(m)(m)-7174.63%(m)-$29.20M(m)$18.39M$16.39M$13.00K
2021-12-31Reported-$38.8M(m)(m)(m)-4167.78%$0.00-$56.37M$3.35M$19.54M$20.30M-$448.00K
2021-09-30Rolling(m)-$52.05M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Rolling(m)-$64.78M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Rolling(m)-$222.41M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported-$252.21M(m)(m)(m)-1201.38%$113.00K-$137.08M$1.39M$43.53M$89.54M-$258.00K
2020-12-31Rolling(m)-$252.55M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Rolling(m)-$267.99M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30Rolling(m)-$267.70M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31Rolling(m)-$119.88M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$95.52M(m)(m)(m)-21562.75%$1.06M-$73.39M$0.00$51.20M$45.11M-$176.00K
2019-12-31Rolling(m)-$95.87M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$74.57M(m)(m)(m)-2074.35%$567.00K-$68.66M$0.00$64.47M$14.01M$212.00K
2017-12-31Reported(m)-$29.59M(m)(m)(m)$27.00K-$28.22M(m)$29.01M(m)$0.00
2016-12-31Reported(m)-$14.33M(m)(m)(m)$31.00K-$2.27M(m)$11.26M(m)(m)
2015-12-31Reported(m)-$4.61M(m)(m)(m)$0.00-$4.18M(m)$2.92M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
HYPERION DEFI, INC. (HYPD)United States$0.065B